These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3923351)

  • 21. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
    George AJ; Tutt AL; Stevenson FK
    J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning of variable fragments of tumor immunoglobulin, assembling and expressing of human SCFV protein in E. coli for anti-idiotype vaccination.
    Meleshko AN; Vashkevich KP; Fomina EG; Scheslenok EP; Schkolina TV; Sergeev GV
    Exp Oncol; 2013 Mar; 35(1):8-14. PubMed ID: 23528309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural profile of idiotype, anti-idiotype and anti-anti-idiotype monoclonal antibodies in the HLA-DQ3 antigenic system.
    Iwasaki Y; Takabatake H; Shinji T; Monestier M; Ferrone S
    Eur J Immunol; 1994 Nov; 24(11):2874-81. PubMed ID: 7957578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody].
    Kon S
    Gan To Kagaku Ryoho; 1988 May; 15(5):1685-92. PubMed ID: 3259417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.
    Foon KA
    N Engl J Med; 1982 Sep; 307(11):686-7. PubMed ID: 6981064
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
    Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
    J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of a conserved idiotope expressed by an autoreactive human B cell lymphoma. Evidence that a VH CDR3 mutation alters idiotypy and specificity.
    Reidl LS; Friedman DF; Goldman J; Hardy RR; Jefferies LC; Silberstein LE
    J Immunol; 1991 Nov; 147(10):3623-31. PubMed ID: 1940361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoselection of B cell hybridomas with anti-idiotypic antisera to study the role of heavy and light chains for idiotype expression and antibody activity.
    Ju ST; Pincus SH; Kunar J; Dorf ME
    J Immunol; 1984 May; 132(5):2485-90. PubMed ID: 6425406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
    King CA; Wills MR; Hamblin TJ; Stevenson FK
    Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of alternative methodologies for the generation of murine monoclonal anti-idiotypic antibodies to human B cell leukemias and lymphomas.
    Giardina SL; Foon KA; Beatty SM; Morgan AC
    J Immunol Methods; 1986 May; 89(1):1-7. PubMed ID: 3517169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of 2 immunoglobulin isotypes, IgM and IgA, with identical idiotype in the B cell lymphoma I.29.
    Sitia R; Rubartelli A; Hammerling U
    J Immunol; 1981 Oct; 127(4):1388-94. PubMed ID: 6974189
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of chronic idiotype suppression by ligands binding to the variable (not the constant) region of the idiotypic target.
    Saito T; Tokuhisa T; Rajewsky K
    Eur J Immunol; 1986 Nov; 16(11):1419-25. PubMed ID: 3096746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous T cell antigen receptor variants of a human T leukemia cell line.
    Maecker HT; Levy R
    J Immunol; 1988 Nov; 141(9):2994-3002. PubMed ID: 3262674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.
    Thielemans K; Maloney DG; Meeker T; Fujimoto J; Doss C; Warnke RA; Bindl J; Gralow J; Miller RA; Levy R
    J Immunol; 1984 Jul; 133(1):495-501. PubMed ID: 6609992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
    Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
    J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable regions of antibodies to synthetic polypeptides. II. Analysis of variable region genes encoding antibodies specific for (T,G)-A--L.
    Carmack CE; Pincus SH
    J Immunol; 1986 Dec; 137(12):3983-9. PubMed ID: 3097139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The VK gene expressed by BALB/c ABPC48 cross-reactive idiotypes induced by anti-idiotypic immunization is identical to that of BALB/c anti-oxazolone and A/J anti-arsonate antibodies.
    Legrain P; Buttin G
    J Immunol; 1985 May; 134(5):3468-73. PubMed ID: 3920322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biclonal B-cell lymphoma.
    Sklar J; Cleary ML; Thielemans K; Gralow J; Warnke R; Levy R
    N Engl J Med; 1984 Jul; 311(1):20-7. PubMed ID: 6427612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.